Linda Avey

Who is Linda Avey?

Linda has over 20 years of sales and business development experience in

the biopharmaceutical industry in San Francisco, Boston, San Diego, and

Washington, D.C. Prior to starting 23andMe, she developed translational

research collaborations with academic and pharmaceutical partners for

Affymetrix and Perlegen Sciences. Linda also spent time at Spotfire

helping scientists understand the power of data visualization and at

Applied Biosystems during the early days of the human genome project.

The advent of high density genome-wide scanning technologies brought

huge potential for significant discoveries. However, the lack of

sufficient funding to enable adequate studies prompted Linda to think

of a new research model. These ideas led to the formation of 23andMe.

Her primary interest is the acceleration of personalized medicine,

using genetic profiles to target the right drug to the right person at

the correct dose. Linda graduated from Augustana College with a B.A. in

biology.